Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Is Obstetric VTE Prophylaxis Use Increasing?

Obstet Gynecol; 2017 Aug; Mardy, Siddiq, et al

Use of venous thromboembolism (VTE) prophylaxis during antepartum and postpartum readmissions increased substantially in the US from 2006 to 2015 and varied based on region and risk factors, a recent study found. The retrospective cohort study analyzed temporal trends of mechanical and pharmacologic VTE prophylaxis for patients hospitalized for antepartum and postpartum indications from 2006 to 2015. A total of 662,740 antepartum and 105,361 postpartum readmissions were included in the analysis. Researchers found:

  • Between 2006 and 2015, use of VTE prophylaxis increased from 18.5% to 38.7% for antepartum admissions and from 22.5% to 30.6% for postpartum readmissions.
  • Among women readmitted postpartum, 56.4% of prophylaxis was pharmacologic and 43.6% was mechanical.
  • For antepartum admissions, 87.2% of prophylaxis was mechanical and only 12.8% was pharmacologic.
  • Some risk factors for VTE were associated with lower rates of prophylaxis.
  • Use of VTE prophylaxis was most common in the South.

Citation:

Mardy AH, Siddiq Z, Ananth CV, Wright JD, D’Alton ME, Friedman AM. Venous thromboembolism prophylaxis during antepartum admissions and postpartum readmissions. Obstet Gynecol. 2017;130(2):270-278. doi:10.1097/AOG.0000000000002099.